Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
What is Tirzepatide and What Makes Its Dual Action Unique
population aged 12 and older (SAMSHA, 2023)
By improving nutrient signaling and reducing appetite dysregulation, GLP-1 therapies may lower stress across multiple organ systems
Lilly says tirzepatide is the first and only approved dual GIP and GLP-1 receptor agonist treatment to reduce excess body weight and maintain weight reduction long-term in combination with diet and exercise
Rosi E, Fastame MT, Silvi G, Guerra P, Nunziati G, Di Cesare A, et al
US$ 22.43
US$ 28.93
US$ 26.62
US$ 27.07
US$ 19.98
US$ 29.68
US$ 23.34
